Objective To Standardize the deployment of the blood gas analyzers in clinical departments, reduce the cost of related
reagents, and improve the delicacy management of in-vitro diagnostic reagents. Methods Based on the economic indicators include
the equipment configuration, using times, operating costs and revenue, the service efficiency and benefit of blood gas analyzers were
investigated, analyzed and evaluated. Results Three blood gas analyzers were checked and reduced by the hospital, and they were
brought into fixed assets management. The average monthly cost of all blood gas analyzers decreased by 43.27%, and the average
monthly cost of a single test decreased by 44.65%.The average monthly income increased by about 2.95%, and the actual test
comprehensive cost rate decreased from 41.00% to about 27.00%. Conclusion The combined service cost and risk of detection can
be controlled through improving the deployment of blood gas, evaluating the service efficiency and benefit.
WANG Qiansup>a, GUO Hongsup>a, WANG Aiyingsup>a, et al. , {{custom_author.name_en}}et al.
Practice and Application on Deployment Impovment of Blood Gas Analyzer and
Cost Control of Related Reagents in Hospital[J].
China Medical Devices, 2020, 35(2): 123-125 https://doi.org/10.3969/j.issn.1674-1633.2020.02.030